Scientists at the National Institutes of Health (NIH) have successfully reduced the severity of late-onset Tay-Sachs (LOTS) ...

As much as we’d like to wish that Tay-Sachs is no longer a problem, the disease remains a deadly foe. But with carrier testing, couples can get the information they need to put the odds on their ...

The story of Tay-Sachs is a miraculous one. It was first identified in the late 1800s by British ophthalmologist Warren Tay and New York neurologist Bernard Sachs, who noticed the disease was ...

Patients in a Phase I/II clinical trial conducted by UMass Chan Medical School of a dual vector gene therapy for GM2 ...

Historically, more than half of patients with GM2 gangliosidosis need to be fed via IV between 13 and 18 months of age. In ...

For a genetic disease like Tay-Sachs, the risk is especially high in the Ashkenazi Jewish population. Whereas 1 in 300 people in the general population are carriers of Tay-Sachs, 1 in 30 Ashkenazi ...

For parents with children with Tay Sachs disease, there's often little hope, no treatment, and no cure. It's a rare and deadly disease that attacks the nerve cells in the brain and spinal cord.